What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
The scientist’s investigation covers issues in Pathology, Neuroblastoma, Internal medicine, Cancer and Cancer research.
Many of his studies involve connections with topics such as Prinomastat and Pathology.
His Neuroblastoma research incorporates elements of Contextual image classification, Stromal cell, Survival analysis and Bone marrow.
His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology, Surgery and Oncology.
In his study, El Niño is inextricably linked to Radiation therapy, which falls within the broad field of Cancer.
His Cancer research research includes themes of Cell culture, Cell adhesion, Matrix metalloproteinase and Cell adhesion molecule.
His most cited work include:
- The International Neuroblastoma Pathology Classification (the Shimada system) (732 citations)
- Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of Neuroblastomas (705 citations)
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study (599 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Pathology, Neuroblastoma, Gerontology and Cognition.
Hiroyuki Shimada works mostly in the field of Internal medicine, limiting it down to topics relating to Surgery and, in certain cases, Ophthalmology, as a part of the same area of interest.
Pathology is represented through his Immunohistochemistry and Histopathology research.
His studies deal with areas such as Cancer, Cancer research and Histology as well as Neuroblastoma.
His work in Gerontology addresses issues such as Confidence interval, which are connected to fields such as Odds ratio.
Hiroyuki Shimada focuses mostly in the field of Cognition, narrowing it down to matters related to Physical therapy and, in some cases, Physical medicine and rehabilitation and Randomized controlled trial.
He most often published in these fields:
- Internal medicine (19.49%)
- Pathology (18.42%)
- Neuroblastoma (16.18%)
What were the highlights of his more recent work (between 2016-2021)?
- Gerontology (13.06%)
- Cognition (11.01%)
- Internal medicine (19.49%)
In recent papers he was focusing on the following fields of study:
Hiroyuki Shimada mainly focuses on Gerontology, Cognition, Internal medicine, Dementia and Neuroblastoma.
His studies in Gerontology integrate themes in fields like Incidence, Geriatrics, Hazard ratio, Confidence interval and Cognitive decline.
Hiroyuki Shimada combines subjects such as Physical therapy, Randomized controlled trial and Audiology with his study of Cognition.
Hiroyuki Shimada usually deals with Internal medicine and limits it to topics linked to Oncology and Chemotherapy.
Hiroyuki Shimada combines subjects such as Neuropsychology, Clinical psychology and Risk factor with his study of Dementia.
He has researched Neuroblastoma in several fields, including Cancer, Cancer research and Pathology, Histology.
Between 2016 and 2021, his most popular works were:
- Prevalence of frailty in Japan: A systematic review and meta-analysis. (94 citations)
- Relationship Between Frailty and Oral Function in Community-Dwelling Elderly Adults. (91 citations)
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. (75 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His main research concerns Gerontology, Dementia, Internal medicine, Confidence interval and Physical therapy.
In the subject of general Gerontology, his work in Older people is often linked to Association, thereby combining diverse domains of study.
The various areas that he examines in his Dementia study include Physical medicine and rehabilitation, Cognition, Cognitive impairment, Alzheimer's disease and Risk factor.
His work carried out in the field of Internal medicine brings together such families of science as Oncology and Neuroblastoma.
Hiroyuki Shimada interconnects Mesenchymal stem cell and Immunology, Bone marrow in the investigation of issues within Neuroblastoma.
His studies examine the connections between Bone marrow and genetics, as well as such issues in Biomarker, with regards to Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
